Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jul;9(3):359-67, vii.
doi: 10.1016/j.hfc.2013.04.003. Epub 2013 May 23.

Noncardiac comorbidities and acute heart failure patients

Robert J Mentz  1 , G Michael Felker
Affiliations
Review

Noncardiac comorbidities and acute heart failure patients

Robert J Mentz et al. Heart Fail Clin. 2013 Jul.

Abstract

The acute heart failure (AHF) population is a heterogeneous group with multiple interrelated noncardiovascular comorbidities. Chronic obstructive pulmonary disease, renal disease, diabetes, sleep apnea, and anemia affect the clinical characteristics and outcomes of patients with AHF and complicate inpatient management. This article summarizes the impact of these noncardiovascular comorbidities in patients with AHF. In some circumstances, careful attention to the diagnosis and management of these conditions in patients with AHF may help to improve patient outcomes.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Interrelated noncardiovascular comorbidities in patients with acute heart failure. COPD, chronic obstructive pulmonary disease.
Fig. 2
Fig. 2
Key characteristics associated with different noncardiovascular comorbidities in patients with acute heart failure. ACE-I, angiotensin-converting enzyme inhibitor; COPD, chronic obstructive pulmonary disease; MRA, mineralocorticoid receptor antagonist.
See this image and copyright information in PMC

References

    1. Adams KF, Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J. 2005;149(2):209–16. - PubMed
    1. O’Connor CM, Abraham WT, Albert NM, et al. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) Am Heart J. 2008;156(4):662–73. - PubMed
    1. Konstam MA, Gheorghiade M, Burnett JC, Jr, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007;297(12):1319–31. - PubMed
    1. Mentz RJ, Lewis EF. Epidemiology of cardiorenal syndrome. Heart Fail Clin. 2010;6(3):333–46. - PubMed
    1. Ambrosy AP, Vaduganathan M, Huffman MD, et al. Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. Eur J Heart Fail. 2012;14(3):302–11. - PubMed

MeSH terms